YTHDC2 and gastric adenocarcinoma: identified a 10-gene signature based on probable predictive m6a regulatory genes, and these genes (METTL3, WTAP, RBM15, RBM15B, YTHDC2, YTHDF2, HNRNPC, FMR1, LRPPRC, and RBMX) were found to be negatively associated with STAD clinical stage.